Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-09

Clinical Trial Update: The Efficacy of a Single Dose of Intranasal Oxytocin in the Prevention of Post Traumatic Stress Disorder (PTSD) [NA]

View source ↗

Summary

A clinical trial evaluating whether a single dose of intranasal oxytocin can prevent post-traumatic stress disorder, but the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intranasal oxytocin (oxytocin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Stress Disorders, Post-Traumatic | NA | Status: UNKNOWN